BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Jayson Punwani will moderate a panel at the 2nd annual Kenan-Flagler Business School Health Care conference on financing innovation.
News | 10. 29. 2012
Jayson Punwani will moderate a panel at the 2nd annual Kenan-Flagler Business School Health Care conference on financing innovation.
